At close: December 20 at 2:43:04 PM GMT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Heikki Lanckriet Ph.D. | CEO, Chief Scientific Officer & Executive Director | 441.2k | -- | 1977 |
| Mr. David Roth | CFO, Company Secretary & Executive Director | 317.9k | -- | 1967 |
4basebio PLC
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 101
Description
4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company offers AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. It also offers access to its targeted non-viral delivery platform, Hermes. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.
Corporate Governance
4basebio PLC’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
September 27, 2024 at 6:00 AM UTC
4basebio PLC Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
HPHA.DE Heidelberg Pharma AG
2.1800
-3.96%
MDG1.DE Medigene AG
1.0320
+0.19%
ALSEN.PA Sensorion SA
0.6180
-1.28%
IMMU.ST Mendus AB (publ)
8.80
+3.99%
ALTME.PA TME Pharma N.V.
0.0746
-1.84%
VICO.ST Vicore Pharma Holding AB (publ)
7.71
-1.91%
ABVX.PA ABIVAX Société Anonyme
7.08
+0.28%
ATORX.ST Alligator Bioscience AB (publ)
0.2635
-1.13%
IVA.PA Inventiva S.A.
2.2500
+2.74%
NYKD.OL Nykode Therapeutics AS
3.0200
+4.57%